Charles River Laboratories International Reiterates FY26 Revenue, Non-GAAP Earnings Outlook, Expects FY30 Organic Revenue Growth In Range Of 5% To 7%

Charles River Laboratories International, Inc. (NYSE: CRL ) will host its 2026 Investor Day today, September 24, 2026, starting at 9:00 a.m. ET. The Company is also introducing the following long-term financial targets through 2030: 2026 GUIDANCE(1) 2030 TARGET(2) Revenue growth, organic (3) Upper end of 0% — 1% growth 5% — 7% 2027-2030 CAGR Non-GAAP operating margin (4) 21.0% — 21.3% ~24% Non-GAAP EPS estimate (4) Upper end of $11.15 — $11.45 Low-double-digit